AQR Capital Management
VTVT icon

AQR Capital Management’s vTv Therapeutics VTVT Stock Holding History

AQR Capital Management’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,316
Closed -$120K – 2338
2021
Q2 		$120K Buy
1,316
+536
+69% +$54.3K ﹤0.01% 2180
2021
Q1 		$88K Buy
+780
New +$76.6K ﹤0.01% 2158

Other funds holding VTVT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WAG
Winthrop Advisory Group Boston, Massachusetts $1.48B AUM 22.62% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $29.1B AUM 22.79% 1-Year Est. Return

AQR Capital Management's VTVT Position: Q3 2021 in Review

AQR Capital Management sold out of vTv Therapeutics (VTVT) in Q3 2021, closing a stake of 1,316 shares — an estimated $120K sold.

AQR Capital Management first reported a position in VTVT in Q1 2021 and held it in 2 quarters. The position peaked at $120K in Q2 2021. 31 funds tracked by Wall St. Rank hold VTVT as of Q3 2021.

  • AQR Capital Management reported no remaining vTv Therapeutics position as of Q3 2021 after selling out during the quarter.
  • AQR Capital Management sold 1,316 vTv Therapeutics shares in Q3 2021, an estimated $120K.
  • AQR Capital Management first reported a position in vTv Therapeutics in Q1 2021 and held it in 2 quarters.
  • AQR Capital Management's vTv Therapeutics position peaked at $120K in Q2 2021.
  • 31 funds tracked by Wall St. Rank held vTv Therapeutics as of Q3 2021.

Based on AQR Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.